FGF19 and primary biliary cholangitis: Of note, based on increase of plasma FGF19 levels, magnitude of FXR stimulation with CDCA 15 mg/kg in the current study appears similar to 10 mg 6-ethyl-chenodeoxycholic acid in primary biliary cirrhosis (the dose currently proposed in this cholestatic liver disease).